{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:42:10Z","timestamp":1765546930067,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.07.015","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T23:05:19Z","timestamp":1658444719000},"page":"5079-5087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pneumococcal meningitis in Greece: A retrospective serotype surveillance study in the post-PCV13 era (2010\u20132020)"],"prefix":"10.1016","volume":"40","author":[{"given":"Athanasia","family":"Xirogianni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nektarios","family":"Marmaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theano","family":"Georgakopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Papandreou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stelmos","family":"Simantirakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Magaziotou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Eliades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Getsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Anastasiou-Katsiardani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efi","family":"Staikou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fani","family":"Markou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Argyr\u03bfpoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Vlachaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genovefa","family":"Chronopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Pangalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodota","family":"Liakopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Michos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Spoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evaggelia","family":"Lagona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Panagiotakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthymia","family":"Petinaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elpis","family":"Mantadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manolis","family":"Galanakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vana","family":"Papaevangelou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Tsolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Tzanakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2022.07.015_b0005","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"Troeger","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.vaccine.2022.07.015_b0010","unstructured":"World Health Organization (WHO). Pneumococcal vaccines position paper 2012. Wkly Epidemiol Rec, 87 (14), pp. 129-144."},{"issue":"1","key":"10.1016\/j.vaccine.2022.07.015_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect."},{"key":"10.1016\/j.vaccine.2022.07.015_b0020","article-title":"Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum","author":"Shea","year":"2014","journal-title":"Infect Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.015_b0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis."},{"issue":"4","key":"10.1016\/j.vaccine.2022.07.015_b0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.vaccine.2022.07.015_b0035","doi-asserted-by":"crossref","unstructured":"Ben-Shimol S, Regev-Yochay G, Givon-Lavi N, Van Der Beek BA, Brosh-Nissimov T, Peretz A, et al.; Israeli Pediatric Bacteremia And Meningitis Group (Ipbmg), And The Israeli Adult Invasive Pneumococcal Disease (Iaipd) Group. Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the PCV13 Era: A Nationwide Prospective Surveillance. Clin Infect Dis. 2021 Jul 22:ciab645. doi: 10.1093\/cid\/ciab645.","DOI":"10.1093\/cid\/ciab645"},{"issue":"1","key":"10.1016\/j.vaccine.2022.07.015_b0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1473-3099(20)30165-1","article-title":"Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study","volume":"21","author":"Ouldali","year":"2021","journal-title":"Lancet Infect Dis."},{"issue":"11","key":"10.1016\/j.vaccine.2022.07.015_b0045","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14760584.2019.1688149","article-title":"Serotype evolution in Western Europe: perspectives on invasive pneumococcal diseases (IPD)","volume":"18","author":"Tin Tin Htar","year":"2019","journal-title":"Expert Rev Vaccines."},{"issue":"48","key":"10.1016\/j.vaccine.2022.07.015_b0050","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1016\/j.vaccine.2014.09.016","article-title":"Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece","volume":"32","author":"Grivea","year":"2014","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2022.07.015_b0055","unstructured":"Greek Ministry of Health. National Immunization Program for Adults 2011. \u0391\u0394\u0391: \u03924\u039b5\u039f\u039e7\u039c-\u039b\u039d8. https:\/\/diavgeia.gov.gr\/doc\/%CE%924%CE%9B5% CE%9F%CE%9E7%CE%9C-%CE%9B%CE%9D8 Accessed March 2022."},{"key":"10.1016\/j.vaccine.2022.07.015_b0060","unstructured":"Greek Ministry of Health. National Immunization Program for Adults 2015. \u0391\u0394\u0391: \u03a95\u03a66\u0398-46\u03a0. https:\/\/www.moh.gov.gr\/articles\/health\/dieythynsh-dhmosias-ygieinhs\/emboliasmoi\/ethniko-programma-emboliasmwn-epe-enhlikwn\/6353-palaiotera-epe-enhlikwn Accessed March 2022."},{"issue":"5","key":"10.1016\/j.vaccine.2022.07.015_b0065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1469-0691.2005.01109.x","article-title":"Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae","volume":"11","author":"Tzanakaki","year":"2005","journal-title":"Clin Microbiol Infect."},{"issue":"12","key":"10.1016\/j.vaccine.2022.07.015_b0070","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.3390\/diagnostics11122353","article-title":"Pneumococcal Serotype Identification by Capsular Sequence Typing (CST): A Modified Novel Approach for Serotyping Directly in Clinical Samples","volume":"11","author":"Marmaras","year":"2021","journal-title":"Diagnostics (Basel)."},{"issue":"5","key":"10.1016\/j.vaccine.2022.07.015_b0075","doi-asserted-by":"crossref","first-page":"e20390","DOI":"10.1371\/journal.pone.0020390","article-title":"Population structure of invasive Streptococcus pneumoniae in The Netherlands in the pre-vaccination era assessed by MLVA and capsular sequence typing","volume":"6","author":"Elberse","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.07.015_b0080","unstructured":"European Centre for Disease Prevention and Control. Invasive pneumococcal disease. In: ECDC. Annual epidemiological report for 2018. Stockholm: ECDC; 2020."},{"issue":"6","key":"10.1016\/j.vaccine.2022.07.015_b0085","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit Health."},{"issue":"2","key":"10.1016\/j.vaccine.2022.07.015_b0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jpids\/piaa035","article-title":"Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use","volume":"10","author":"Baxter","year":"2021","journal-title":"J Pediatric Infect Dis Soc."},{"issue":"9","key":"10.1016\/j.vaccine.2022.07.015_b0095","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1473-3099(18)30349-9","article-title":"French Pediatric Meningitis Network. Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey","volume":"18","author":"Ouldali","year":"2018","journal-title":"Lancet Infect Dis."},{"issue":"4","key":"10.1016\/j.vaccine.2022.07.015_b0100","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.vaccine.2017.11.085","article-title":"Invasive pneumococcal disease in children under 16 years of age: Incomplete rebound in incidence after the maximum effect of PCV13 in 2012\/13 in Germany","volume":"36","author":"Weinberger","year":"2018","journal-title":"Vaccine."},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.015_b0105","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0567","article-title":"Invasive Pneumococcal Disease in Children's Hospitals: 2014\u20132017","volume":"144","author":"Kaplan","year":"2019","journal-title":"Pediatrics"},{"issue":"35","key":"10.1016\/j.vaccine.2022.07.015_b0110","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2018.07.055","article-title":"Characteristics of Streptococcus pneumoniae serotype 19A isolates from children in the pre and post Conjugate Vaccine Era. Single center experience 1986\u20132015","volume":"36","author":"Koutouzis","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.015_b0115","doi-asserted-by":"crossref","unstructured":"Groves N, Sheppard CL, Litt D, Rose S, Silva A, Njoku N, et al. Evolution of Streptococcus pneumoniae Serotype 3 in England and Wales: A Major Vaccine Evader. Genes (Basel). 2019 Oct 25;10(11):845. doi: 10.3390\/genes10110845.","DOI":"10.3390\/genes10110845"},{"issue":"10","key":"10.1016\/j.vaccine.2022.07.015_b0120","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/14760584.2017.1362339","article-title":"Streptococcus pneumoniae serotype 19A: worldwide epidemiology","volume":"16","author":"Isturiz","year":"2017","journal-title":"Expert Rev Vaccines."},{"issue":"12","key":"10.1016\/j.vaccine.2022.07.015_b0125","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/cid\/ciy920","article-title":"Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies","volume":"68","author":"Sings","year":"2019","journal-title":"Clin Infect Dis."},{"issue":"7","key":"10.1016\/j.vaccine.2022.07.015_b0130","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/cid\/cix418","article-title":"Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006\u20132014","volume":"65","author":"Oligbu","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2022.07.015_b0135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3201\/eid2606.190951","article-title":"Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2\u201359 Months of Age","volume":"26","author":"Hern\u00e1ndez","year":"2020","journal-title":"Spain. Emerg Infect Dis."},{"issue":"11","key":"10.1016\/j.vaccine.2022.07.015_b0140","doi-asserted-by":"crossref","first-page":"e3778","DOI":"10.1093\/cid\/ciaa1483","article-title":"Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine Era","volume":"73","author":"de Miguel","year":"2021","journal-title":"Clin Infect Dis."},{"issue":"9","key":"10.1016\/j.vaccine.2022.07.015_b0145","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3201\/eid2509.180747","article-title":"Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016","volume":"25","author":"Oligbu","year":"2019","journal-title":"Emerg Infect Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2022.07.015_b0150","doi-asserted-by":"crossref","first-page":"e0177113","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.07.015_b0155","doi-asserted-by":"crossref","unstructured":"Beall B, Chochua S, Gertz RE Jr, Li Y, Li Z, McGee L, et al. A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015-2016. Front Microbiol. 2018 Nov 19;9:2670. doi: 10.3389\/fmicb.2018.02670.","DOI":"10.3389\/fmicb.2018.02670"},{"issue":"5","key":"10.1016\/j.vaccine.2022.07.015_b0160","doi-asserted-by":"crossref","first-page":"e1000081","DOI":"10.1371\/journal.pmed.1000081","article-title":"Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study","volume":"6","author":"Harboe","year":"2009","journal-title":"PLoS Med."},{"issue":"11","key":"10.1016\/j.vaccine.2022.07.015_b0165","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3201\/eid1611.100941","article-title":"Prevalence and genetic structures of Streptococcus pneumoniae serotype 6D","volume":"16","author":"Choi","year":"2010","journal-title":"South Korea. Emerg Infect Dis."},{"issue":"8","key":"10.1016\/j.vaccine.2022.07.015_b0170","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jiac.2016.04.005","article-title":"Clinical and microbiological characterization of serotype 6D pneumococcal infections in South Korea","volume":"22","author":"Cheong","year":"2016","journal-title":"J Infect Chemother."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:18Z","timestamp":1759403718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22008908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":34,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X22008908"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal meningitis in Greece: A retrospective serotype surveillance study in the post-PCV13 era (2010\u20132020)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}